dose proportionality in some pharmacokinetic parameters for thioridazine and its two active metabolites ( mesoridazine and sulforidazine ) was investigated in 11 healthy human subjects following oral administration of three single doses ( 25 , 50 , and 100 mg ) of thioridazine hydrochloride separated in each case by an interval of two weeks .
C0039943
thioridazine
C0700499
thioridazine hydrochloride